The Royal Cornwall Hospital, formerly and still commonly known as the Treliske Hospital, is a medium-sized teaching hospital in Treliske, on the outskirts of Truro, Cornwall, England. The hospital provides training services for the University of Exeter Medical School.

There are 760 beds in Royal Cornwall Hospital; Dept of Clinical Oncology.

During the past decade, Royal Cornwall Hospital; Dept of Clinical Oncology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Cornwall Hospital; Dept of Clinical Oncology" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Royal Cornwall Hospital; Dept of Clinical Oncology" are "Breast Cancer" (7 trials), "Colorectal Cancer" (1 trials), "Locally Advanced or Metastatic Breast Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Royal Cornwall Hospital; Dept of Clinical Oncology" in a lesser frequency.

Most popular intervention types in "Royal Cornwall Hospital; Dept of Clinical Oncology" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (5 trials), "Docetaxel" (4 trials), "Pertuzumab" (4 trials), "Paclitaxel" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Royal Cornwall Hospital; Dept of Clinical Oncology" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Royal Cornwall Hospital; Dept of Clinical Oncology". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Royal Cornwall Hospital; Dept of Clinical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Cornwall Hospital; Dept of Clinical Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".